Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9337055Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award categories
- Pharmacology
NIH Funding · FY2024
Linked Award Amount
$2.2M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#4,399
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Christopher Hulme as a PI. Multi-PI records show the full award amount for context.
- 4R44NS129400-02R44Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome$1.5Maward amount
- 5R01AG067926-05R01DYRK1A Inhibition as a Novel Treatment Approach for Alzheimer's Disease$736.6Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Christopher Hulme as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardIluminos Therapeutics, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4399
- 2024Entered Top 25% NationallyRanked #4399
- 2024R01 Grant Holder
- 2025Multi-Institutional ResearchAwards at 2 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Christopher Hulme.